医疗行业不反对改革,只反对你赢太大The Industry Doesn't Fear Reform. It Fears You Winning Too Big
美国医疗行业正在为中期选举布防,但它要防的不是「改革」,是「民主党赢太大」。Vox 这篇报道把这个区别写得很清楚:行业短期甚至欢迎民主党拿下众议院,因为那意味着 Medicaid 和 ACA 的削减能被挡住、政策更可预测;它真正怕的是参议院也翻蓝、2028 年白宫也拿下,那时候 Medicare-for-all 才会从口号变成议程。所以这不是一场关于「该不该改」的辩论,是一场关于「改到哪一步为止」的定价。
定价权已经在用了。俄亥俄州参议院选战里,美国医院协会 PAC 和 PhRMA 合计给共和党现任 Jon Husted 一万四千五百美元,给民主党挑战者 Sherrod Brown 零;缅因州 Susan Collins 拿到医院、药企、保险、医生四大行业团体的捐款,对手 Troy Jackson 一分没有,他自己也声明不收企业 PAC 的钱。爱荷华那场没有现任者的开放席位同样如此。2016 年看起来要变天的时候,药企在竞争性选区以六比一的钱押共和党,想掐死希拉里·克林顿的议程。同一套动作,换了个年份。
这是第三章说的那种武器化:不必说服你相信什么,只要先定义「什么是负责任的方案」。得州共和党团体拿一份行业委托的研究打 James Talarico,说他支持 Medicare-for-all 会让乡村医院被砍;宾州对 Janelle Stelson 用了同一套广告。信息很统一——你的方案听起来好,但你会失去保险、失去医生、多交税。更关键的是那句行业老话:每个国会选区都有一家医院,所以每个议员都怕自己选区的医院关门、岗位消失。这把「病人的风险」和「本地的就业」焊在一起,让结构性改革在进入辩论之前就先背上了直接伤害的罪名。
再看谁在共谋、回报是什么。保险业 PAC 给两党领袖和主管医疗的委员会资深议员各塞了数万美元,这是在对明年排议程的人做多线下注。中间派民主党团体拿着行业支持,公开说要对 Medicare-for-all「准备开战」。行业自己的说法由 KFF 的 Larry Levitt 讲得最直白:欢迎更多人获得覆盖、欢迎稳定的政府出资,但会「围起篷车」打 Medicare-for-all。翻译一下:接受你给我补贴参保人,不接受你动我的收费结构。
这里要分清结构层和文化层怎么联动。结构层是钱和席位:参议院差一席,法案就写不出来。文化层是叙事:把「政府主导」预先等同于「你会失去你现在的保险」,让恐惧先于方案落地。两层咬合的地方,就是行业不用赢下辩论,只要让辩论不发生。
报道里也确实有人在付代价,而且代价正在变大。疫情时期的保护措施到期后,未参保率在上升;OBBBA 里那一万亿美元的 Medicaid 削减已经让诊所和医院裁人、关停。北卡教授 Jonathan Oberlander 说,还不确定有没有人真正消化了这会有多具破坏性——包括对医院自己。Gallup 的数据是五成美国人对医疗行业持负面看法,三成七正面;六成四的人认为让所有人有医保是政府的责任,除 2000 年代末 ACA 立法前夕之外,这是最高的一次。八成一的人认为医院定价不合理。行业那套「我们最穷、给我们更多钱」的说辞,按 Kim Monk 的说法,已经有点撑不住了。
所以真正的变量不是行业会不会反扑——它一直在反扑——而是未参保的人再多到什么程度,恐惧的账才会算到另一边。现在行业押的是:你会怕失去你已经有的那点东西,胜过怕继续失去更多。这个赌注成立的前提,是那点东西还在。
The US healthcare industry is digging in for the midterms, and what it is defending against is not "reform" but "Democrats winning too big." Vox lays the distinction out plainly: in the short term the industry would even welcome a Democratic House, because that means the Medicaid and ACA cuts get blocked and policy becomes more predictable. What it actually fears is the Senate flipping too, and the White House in 2028, when Medicare-for-all stops being a slogan and becomes an agenda item. This is not a debate about whether to change things. It is a negotiation over where the change stops.
The pricing power is already in use. In the Ohio Senate race, the American Hospital Association PAC and PhRMA gave a combined $14,500 to Republican incumbent Jon Husted and nothing to his Democratic challenger Sherrod Brown. In Maine, Susan Collins collected donations from all the major healthcare trade groups — hospitals, pharma, insurers, doctors — while Troy Jackson got none, and he has sworn off corporate PAC money anyway. The open Iowa race went the same way. In 2016, when it looked like a wave year, the drug industry put money into Republican campaigns in competitive races by a six-to-one margin to strangle Hillary Clinton's agenda. Same move, different year.
This is the weaponization playbook: you don't have to convince people of anything if you can define what counts as a "responsible" proposal first. Republican groups in Texas leaned on an industry-commissioned study to attack James Talarico over Medicare-for-all, warning it would cut rural hospitals; the same ad ran against Janelle Stelson in Pennsylvania. The message is uniform — your plan sounds nice, but you'll lose your plan, your doctor, and pay higher taxes. And there is the old DC line: every congressional district has a hospital, so every member fears that new legislation means their own constituents lose jobs. Patient risk gets welded to local employment, and structural reform arrives at the debate already carrying the charge of direct harm.
Look at who is conspiring and what they get. Insurance PACs have handed tens of thousands of dollars to leaders of both parties and to senior members of the healthcare committees — multi-track bets on the people who will set next year's agenda. Centrist Democratic groups that receive industry support have said they are "preparing for war" against Medicare-for-all. The industry's own position is stated most cleanly by KFF's Larry Levitt: all for more people having coverage and stable government financing, but they will circle the wagons to fight Medicare-for-all. Translation: take my subsidies for enrollees, don't touch my pricing structure.
Note how the structural and cultural layers interlock. The structural layer is money and seats: one Senate seat short and no bill gets drafted. The cultural layer is narrative: pre-equate "government-run" with "you lose the coverage you have," so fear arrives before any proposal does. Where the two mesh, the industry doesn't need to win the argument. It only needs the argument not to happen.
And people are paying, with the bill getting larger. The uninsured rate has been rising as pandemic protections expire; the $1 trillion in Medicaid cuts in the OBBBA has already led clinics and hospitals to lay off staff or close. Jonathan Oberlander of UNC says he is not sure anyone has fully absorbed how damaging and disruptive that will be — including to hospitals and health systems. Gallup has 50 percent of Americans viewing the industry negatively against 37 percent positively; 64 percent say it is the government's responsibility to ensure everyone has coverage, the highest share outside the late 2000s just before the ACA. Eighty-one percent call hospital prices unreasonable. The "we're the poorest, just give us more money" pitch, as Kim Monk puts it, is wearing thin.
The real variable is not whether the industry fights back — it always does — but at what point the fear calculus flips because there is nothing left to lose. The industry is betting you fear losing what you have more than you fear losing more. That bet holds only as long as there is something left to lose.